NASDAQ:INNT - Innovate Biopharmaceuticals News Headlines

$0.88
+0.01 (+1.15 %)
(As of 08/23/2019 04:00 PM ET)
Today's Range
$0.85
Now: $0.8816
$0.92
50-Day Range
$0.77
MA: $1.00
$1.16
52-Week Range
$0.73
Now: $0.8816
$9.68
Volume68,369 shs
Average Volume226,181 shs
Market Capitalization$31.63 million
P/E RatioN/A
Dividend YieldN/A
Beta-2.63

Headlines

Innovate Biopharmaceuticals (NASDAQ INNT) News Headlines

Source:
DateHeadline
Innovate Biopharmaceuticals Inc (NASDAQ:INNT) Sees Large Growth in Short InterestInnovate Biopharmaceuticals Inc (NASDAQ:INNT) Sees Large Growth in Short Interest
www.americanbankingnews.com - August 16 at 4:53 PM
Innovate Biopharmaceuticals, Inc. Announces First Patient Dosed in the First Phase 3 Clinical Trial for Patients with Celiac DiseaseInnovate Biopharmaceuticals, Inc. Announces First Patient Dosed in the First Phase 3 Clinical Trial for Patients with Celiac Disease
finance.yahoo.com - August 13 at 12:05 PM
Innovate Biopharmaceuticals Reports Second Quarter 2019 Results and Corporate UpdatesInnovate Biopharmaceuticals Reports Second Quarter 2019 Results and Corporate Updates
finance.yahoo.com - August 8 at 9:27 PM
Innovate Biopharmaceuticals Inc (NASDAQ:INNT) Expected to Announce Earnings of -$0.16 Per ShareInnovate Biopharmaceuticals Inc (NASDAQ:INNT) Expected to Announce Earnings of -$0.16 Per Share
www.americanbankingnews.com - August 6 at 7:25 AM
Innovate Biopharmaceuticals (INNT) to Release Quarterly Earnings on ThursdayInnovate Biopharmaceuticals (INNT) to Release Quarterly Earnings on Thursday
www.americanbankingnews.com - August 1 at 2:55 AM
Investors Who Bought Innovate Biopharmaceuticals (NASDAQ:INNT) Shares A Year Ago Are Now Down 82%Investors Who Bought Innovate Biopharmaceuticals (NASDAQ:INNT) Shares A Year Ago Are Now Down 82%
finance.yahoo.com - July 19 at 1:09 PM
Innovate Biopharmaceuticals Announces Corporate Update and Expected Date for Second Quarter Earnings ReleaseInnovate Biopharmaceuticals Announces Corporate Update and Expected Date for Second Quarter Earnings Release
finance.yahoo.com - July 16 at 11:16 AM
Triangle pharma brings in new CFO looking for capitalTriangle pharma brings in new CFO looking for capital
finance.yahoo.com - June 25 at 8:16 AM
Triangle drugmaker launches historic trial for celiac diseaseTriangle drugmaker launches historic trial for celiac disease
finance.yahoo.com - June 11 at 11:51 AM
Innovate Biopharmaceuticals Announces the Start of the First Phase 3 Clinical Trial in Celiac DiseaseInnovate Biopharmaceuticals Announces the Start of the First Phase 3 Clinical Trial in Celiac Disease
finance.yahoo.com - June 10 at 12:02 PM
Innovate Biopharmaceuticals Announces Presentation of Three Posters Focusing on the Molecular Biology and Pharmacology of Larazotide at the 2019 Digestive Disease Week Conference in San DiegoInnovate Biopharmaceuticals Announces Presentation of Three Posters Focusing on the Molecular Biology and Pharmacology of Larazotide at the 2019 Digestive Disease Week Conference in San Diego
finance.yahoo.com - May 20 at 10:09 AM
Innovate Biopharma -3.8% on holders offering of 15.1M sharesInnovate Biopharma -3.8% on holders' offering of 15.1M shares
seekingalpha.com - May 18 at 8:49 AM
Innovate Biopharma Announces Analyst Event on Monday, May 20, 2019, in San DiegoInnovate Biopharma Announces Analyst Event on Monday, May 20, 2019, in San Diego
finance.yahoo.com - May 9 at 11:34 AM
Innovate Biopharmaceuticals Announces Closing of $8.7 Million Registered Direct OfferingInnovate Biopharmaceuticals Announces Closing of $8.7 Million Registered Direct Offering
finance.yahoo.com - May 2 at 11:37 AM
Edited Transcript of INNT earnings conference call or presentation 29-Apr-19 12:00pm GMTEdited Transcript of INNT earnings conference call or presentation 29-Apr-19 12:00pm GMT
finance.yahoo.com - May 1 at 11:13 AM
Rollercoaster ride for Innovate stock on Wall Street MondayRollercoaster ride for Innovate stock on Wall Street Monday
www.bizjournals.com - April 29 at 4:06 PM
Innovate Biopharmaceuticals, Inc. (INNT) CEO Sandeep Laumas on Q1 2019 Results - Earnings Call TranscriptInnovate Biopharmaceuticals, Inc. (INNT) CEO Sandeep Laumas on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - April 29 at 4:06 PM
Roller-coaster ride for Innovate's stock on Wall Street MondayRoller-coaster ride for Innovate's stock on Wall Street Monday
finance.yahoo.com - April 29 at 4:06 PM
Innovate Bio up 27% premarket on positive preclinical NASH dataInnovate Bio up 27% premarket on positive preclinical NASH data
seekingalpha.com - April 29 at 11:16 AM
Innovate Biopharmaceuticals Shows Larazotide is the First Drug, with its Novel Mechanism of ActionInnovate Biopharmaceuticals Shows Larazotide is the First Drug, with its Novel Mechanism of Action
www.nasdaq.com - April 29 at 11:16 AM
Innovate Biopharmaceuticals Shows Larazotide is the First Drug, with its Novel Mechanism of Action of Re-normalizing the Intestinal Barrier, to Demonstrate Improvements in validated NASH Biomarkers and Endpoints in synergy with obeticholic acid, an FXR agonist, and Reports key first quarter 2019 financial results and operational highlightsInnovate Biopharmaceuticals Shows Larazotide is the First Drug, with its Novel Mechanism of Action of Re-normalizing the Intestinal Barrier, to Demonstrate Improvements in validated NASH Biomarkers and Endpoints in synergy with obeticholic acid, an FXR agonist, and Reports key first quarter 2019 financial results and operational highlights
finance.yahoo.com - April 29 at 11:16 AM
Innovate Biopharmaceuticals First Quarter 2019 Financial Results and Operational Progress Updates - Webcast DetailsInnovate Biopharmaceuticals First Quarter 2019 Financial Results and Operational Progress Updates - Webcast Details
finance.yahoo.com - April 26 at 4:09 PM
Innovate Biopharmaceuticals Presents Oral Poster at European Association for the Study of the LiverInnovate Biopharmaceuticals Presents Oral Poster at European Association for the Study of the Liver
www.nasdaq.com - April 11 at 4:12 PM
Innovate Biopharmaceuticals Presents Oral Poster at European Association for the Study of the Liver (EASL) Demonstrating Positive Effect of Larazotide on Reduced Intestinal Permeability in a NASH Preclinical StudyInnovate Biopharmaceuticals Presents Oral Poster at European Association for the Study of the Liver (EASL) Demonstrating Positive Effect of Larazotide on Reduced Intestinal Permeability in a NASH Preclinical Study
finance.yahoo.com - April 11 at 4:12 PM
Innovate Biopharmaceuticals to Announce First Quarter 2019 Financial Results and to Provide Operational Progress Updates on April 29, 2019Innovate Biopharmaceuticals to Announce First Quarter 2019 Financial Results and to Provide Operational Progress Updates on April 29, 2019
finance.yahoo.com - April 2 at 11:14 AM
Innovate reiterates the start of the first Phase 3 clinical trial in celiac disease in Q2 2019Innovate reiterates the start of the first Phase 3 clinical trial in celiac disease in Q2 2019
www.globenewswire.com - March 26 at 12:01 PM
Innovate Biopharmaceuticals Announces Collaboration with Institut Gustave Roussy to Study Regulation of Intestinal Permeability and the Gut Microbiota using Larazotide in Immuno-oncology Checkpoint Inhibitor Failure Pre-Clinical ModelsInnovate Biopharmaceuticals Announces Collaboration with Institut Gustave Roussy to Study Regulation of Intestinal Permeability and the Gut Microbiota using Larazotide in Immuno-oncology Checkpoint Inhibitor Failure Pre-Clinical Models
finance.yahoo.com - March 26 at 12:01 PM
Innovate Biopharma raises more cash, chases treatment for celiac diseaseInnovate Biopharma raises more cash, chases treatment for celiac disease
finance.yahoo.com - March 20 at 4:25 PM
Innovate Biopharmaceuticals, Inc. (INNT) CEO Sandeep Laumas on Q4 2018 Results - Earnings Call TranscriptInnovate Biopharmaceuticals, Inc. (INNT) CEO Sandeep Laumas on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - March 19 at 4:23 PM
Why the FDA Commissioner Pushed To Shorten Medical Device Approval ProcessWhy the FDA Commissioner Pushed To Shorten Medical Device Approval Process
www.marketwatch.com - March 19 at 12:03 PM
Innovate Biopharmaceuticals to Discuss Fourth Quarter and Full Year 2018 Financial Results and to Provide Corporate and Operational Progress Updates on March 19, 2019Innovate Biopharmaceuticals to Discuss Fourth Quarter and Full Year 2018 Financial Results and to Provide Corporate and Operational Progress Updates on March 19, 2019
finance.yahoo.com - March 19 at 12:03 PM
Innovate Biopharmaceuticals Reports Financing to Initiate the First Phase 3 Clinical Trial in Celiac Disease, Fiscal Year 2018 Earnings and Key Corporate HighlightsInnovate Biopharmaceuticals Reports Financing to Initiate the First Phase 3 Clinical Trial in Celiac Disease, Fiscal Year 2018 Earnings and Key Corporate Highlights
finance.yahoo.com - March 19 at 12:03 PM
Innovate Bio up 19% in capital raise to fund late-stage INN-202 studyInnovate Bio up 19% in capital raise to fund late-stage INN-202 study
seekingalpha.com - March 18 at 4:25 PM
Innovate Pharmaceuticals banks another $5.5 millionInnovate Pharmaceuticals banks another $5.5 million
www.bizjournals.com - March 18 at 4:25 PM
Innovate Biopharmaceuticals Announces Entry Into Securities Purchase Agreement to Fund Initiation of the First Phase 3 Celiac Disease Clinical Trial - NasdaqInnovate Biopharmaceuticals Announces Entry Into Securities Purchase Agreement to Fund Initiation of the First Phase 3 Celiac Disease Clinical Trial - Nasdaq
www.nasdaq.com - March 18 at 11:02 AM
Innovate Biopharmaceuticals Announces Entry Into Securities Purchase Agreement to Fund Initiation of the First Phase 3 Celiac Disease Clinical TrialInnovate Biopharmaceuticals Announces Entry Into Securities Purchase Agreement to Fund Initiation of the First Phase 3 Celiac Disease Clinical Trial
finance.yahoo.com - March 18 at 11:02 AM
Form 8-K INNOVATE BIOPHARMACEUTIC For: Mar 08 - StreetInsider.comForm 8-K INNOVATE BIOPHARMACEUTIC For: Mar 08 - StreetInsider.com
www.streetinsider.com - March 14 at 12:06 PM
Innovate Biopharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results and to Provide Corporate and Operational Progress Updates on March 18, 2019Innovate Biopharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results and to Provide Corporate and Operational Progress Updates on March 18, 2019
finance.yahoo.com - March 14 at 12:06 PM
Innovate Biopharmaceuticals Announces Presentation at Cowen’s 39th Annual Health Care Conference in BostonInnovate Biopharmaceuticals Announces Presentation at Cowen’s 39th Annual Health Care Conference in Boston
finance.yahoo.com - March 6 at 11:34 AM
Innovate Biopharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results and to Provide Corporate and Operational Progress Updates on March 14, 2019 - GlobeNewswireInnovate Biopharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results and to Provide Corporate and Operational Progress Updates on March 14, 2019 - GlobeNewswire
globenewswire.com - March 3 at 10:21 AM
Innovate Biopharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results and toInnovate Biopharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results and to
www.nasdaq.com - March 2 at 10:59 AM
Innovate Biopharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results and to Provide Corporate and Operational Progress Updates on March 14, 2019Innovate Biopharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results and to Provide Corporate and Operational Progress Updates on March 14, 2019
finance.yahoo.com - March 2 at 10:58 AM
Innovate Biopharmaceuticals Schedules Conference Call to Provide Corporate and Operational Progress Updates - GlobeNewswireInnovate Biopharmaceuticals Schedules Conference Call to Provide Corporate and Operational Progress Updates - GlobeNewswire
globenewswire.com - February 28 at 12:14 PM
Innovate Biopharmaceuticals Schedules Conference Call to Provide Corporate and Operational Progress UpdatesInnovate Biopharmaceuticals Schedules Conference Call to Provide Corporate and Operational Progress Updates
finance.yahoo.com - February 26 at 12:26 PM
Innovate Biopharmaceuticals Announces Acceptance of Three Abstracts Focusing on the Molecular Biology and Pharmacology of Larazotide for the 2019 Digestive Disease Week ConferenceInnovate Biopharmaceuticals Announces Acceptance of Three Abstracts Focusing on the Molecular Biology and Pharmacology of Larazotide for the 2019 Digestive Disease Week Conference
finance.yahoo.com - February 25 at 11:10 AM
Innovate Biopharmaceuticals Inc.Innovate Biopharmaceuticals Inc.
www.barrons.com - February 22 at 4:14 PM
Innovate Biopharmaceuticals Announces a New Chief Executive Officer and Chief Medical OfficerInnovate Biopharmaceuticals Announces a New Chief Executive Officer and Chief Medical Officer
finance.yahoo.com - February 22 at 4:14 PM
Innovate Biopharmaceuticals Announces Presentation at BIO CEO & Investor ConferenceInnovate Biopharmaceuticals Announces Presentation at BIO CEO & Investor Conference
finance.yahoo.com - February 7 at 11:28 AM
CytoDyn Appoints David F. Welch, Ph.D. to Board of Directors - NasdaqCytoDyn Appoints David F. Welch, Ph.D. to Board of Directors - Nasdaq
www.nasdaq.com - January 11 at 3:50 PM
3 Biggest Stories at the J.P. Morgan Healthcare Conference This Year - Motley Fool3 Biggest Stories at the J.P. Morgan Healthcare Conference This Year - Motley Fool
www.fool.com - January 11 at 3:50 PM
This page was last updated on 8/24/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel